They are now commonly used when: Metformin alone is no longer enough Weight gain is contributing to worsening glucose control There is a need to minimise hypoglycaemia risk Someone has existing cardiovascular disease or multiple risk factors For many people, GLP-1 therapy can delay or reduce the need for insulin, or allow insulin doses to be kept lower and safer
Actin-like protein 6A (ACTL6A), also known as 53 kDa BRG-1/human BRM-associated factor (BAF53a), is involved in diverse cellular processes, such as vesicular transport, spindle orientation, nuclear migration, the cell cycle, and chromatin remodeling 6,7,8,9
Patients should contact their healthcare provider if they experience persistent or severe dehydration symptoms, orthostatic dizziness, inability to keep fluids down, or very low urine output
Exercise Intolerance: Rapidly hyper-activating the purine salvage pathway prevents the "washout" of degraded energy metabolites, allowing skeletal muscles to recover their contractile strength and endurance more efficiently after activity
[PubMed ID: 36710351]
